LILRA1
Basic information
Region (hg38): 19:54593582-54602381
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LILRA1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 33 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 33 | 5 | 0 |
Variants in LILRA1
This is a list of pathogenic ClinVar variants found in the LILRA1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-54594261-C-A | not specified | Uncertain significance (Apr 17, 2024) | ||
19-54594272-T-G | not specified | Uncertain significance (Apr 25, 2023) | ||
19-54594453-G-A | not specified | Uncertain significance (Feb 07, 2023) | ||
19-54594462-C-T | not specified | Uncertain significance (Oct 31, 2022) | ||
19-54594764-A-G | not specified | Uncertain significance (May 16, 2024) | ||
19-54594808-C-T | not specified | Uncertain significance (Apr 12, 2024) | ||
19-54594818-A-G | not specified | Uncertain significance (Nov 15, 2021) | ||
19-54594844-C-T | not specified | Likely benign (Dec 16, 2022) | ||
19-54594901-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
19-54594932-C-T | not specified | Uncertain significance (Feb 13, 2024) | ||
19-54595129-C-A | not specified | Uncertain significance (Nov 18, 2022) | ||
19-54595162-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
19-54595256-C-T | not specified | Uncertain significance (Jun 02, 2023) | ||
19-54595261-A-G | not specified | Uncertain significance (Mar 16, 2022) | ||
19-54595271-G-T | not specified | Uncertain significance (Dec 11, 2023) | ||
19-54595351-T-C | not specified | Uncertain significance (Sep 22, 2022) | ||
19-54595357-C-T | not specified | Likely benign (Dec 08, 2023) | ||
19-54595648-A-G | not specified | Likely benign (Jul 05, 2023) | ||
19-54595699-G-T | not specified | Uncertain significance (Apr 08, 2024) | ||
19-54595726-T-C | not specified | Uncertain significance (Mar 03, 2022) | ||
19-54595864-G-C | not specified | Uncertain significance (Jun 10, 2024) | ||
19-54595865-A-T | not specified | Uncertain significance (Oct 04, 2022) | ||
19-54595870-C-A | not specified | Likely benign (Aug 10, 2021) | ||
19-54595872-G-T | not specified | Uncertain significance (Dec 21, 2022) | ||
19-54595888-C-T | not specified | Uncertain significance (Mar 19, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LILRA1 | protein_coding | protein_coding | ENST00000251372 | 9 | 8509 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.39e-20 | 0.000513 | 125719 | 0 | 29 | 125748 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -2.17 | 381 | 279 | 1.36 | 0.0000165 | 3075 |
Missense in Polyphen | 86 | 70.514 | 1.2196 | 946 | ||
Synonymous | -5.43 | 192 | 117 | 1.64 | 0.00000714 | 1027 |
Loss of Function | -0.757 | 27 | 23.1 | 1.17 | 0.00000100 | 260 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000514 | 0.000514 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000796 | 0.0000791 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May act as receptor for class I MHC antigens.;
- Pathway
- Osteoclast differentiation - Homo sapiens (human);Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System
(Consensus)
Intolerance Scores
- loftool
- 0.919
- rvis_EVS
- 2.54
- rvis_percentile_EVS
- 98.72
Haploinsufficiency Scores
- pHI
- 0.0381
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.522
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.140
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- adaptive immune response;defense response;cell surface receptor signaling pathway;regulation of immune response
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- antigen binding;transmembrane signaling receptor activity